Package 51655-703-04

{"route": ["ORAL"], "spl_id": "4950f429-3a5a-cfbc-e063-6294a90a5193", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564"], "spl_set_id": ["f98aea50-e4d9-c0cc-e053-6294a90a811c"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-703-04)", "package_ndc": "51655-703-04", "marketing_start_date": "20230815"}, {"sample": false, "description": "21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-703-21)", "package_ndc": "51655-703-21", "marketing_start_date": "20230403"}, {"sample": false, "description": "10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-703-53)", "package_ndc": "51655-703-53", "marketing_start_date": "20230615"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "51655-703_4950f429-3a5a-cfbc-e063-6294a90a5193", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "51655-703", "generic_name": "Valacyclovir Hydrochloride", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1 g/1"}], "application_number": "ANDA090682", "marketing_category": "ANDA", "marketing_start_date": "20230403", "listing_expiration_date": "20271231"}